PDCD1 and cancer: Programmed cell death protein-1 (PD-1) and programmed cell death protein- ligand 1 (PD-L1) are the two most intensively studied immune regulatory checkpoint pathways in cancer (1), which relies on the presence of ongoing antitumor immune response after blocking this pathway (2).